The 131st Annual Meeting (November 15-19, 2003) of APHA |
Gabremaskal Habtemariam, PhD, Senait Tibebu, MSc, and Yeshewamebrat Ejigsew, MSc. Pathfinder International-Ethiopia Office, 9 Galen Street, Suite 217, Watertown, MA 02472, (617) 924-7200, ghainsworth@pathfind.org
The Ethiopia DHS (2000) shows a significant gap between knowledge and use of modern contraceptives in general and IUCDs in particular. While 81% of women knew at least one contraceptive method, use amongst married women remains low at 10.7% for pills, 5.5% for injectables, and 0.5% for IUCDs. This data was validated by a Pathfinder rapid survey (2001) of its subprojects. Knowledge of pills was 83% to 95%, injectables 56% to 92%, and IUCD 3% to 35% while use of pills was 29% to 58%, injectables 29% to 69%, and IUCD 0% to 4.3% .
IUCDs are particularly suitable for countries like Ethiopia where access to services can be difficult. Advantages include long duration of protection, safety, effectiveness, and minimal need for medical consultation except when side effects are noted. Despite these advantages and the fact that community-based workers are supposed to be providing full information on all methods to enable informed choice, both knowledge and use of IUCDs is below expectation.
Pathfinder is conducting a study to investigate low IUCD usage and identify approaches for improvement. The objectives are to investigate: (a) adequacy, objectiveness, and clarity of provider information; (b) availability of services (trained personnel, equipment and supplies); and (c) rumors that may influence usage. It is a cross-sectional study of female FP users, community workers, and referral health care facilities. Data is primarily based on service delivery information and women’s knowledge and perceptions of IUCDs. The study will identify factors that influence the use of IUCDs.
Learning Objectives:
Keywords: Family Planning, Developing Countries
Presenting author's disclosure statement:
I do not have any significant financial interest/arrangement or affiliation with any organization/institution whose products or services are being discussed in this session.